{"title":"神经发育障碍患者、照顾者和工作人员的接受和承诺治疗的系统回顾。","authors":"Yors Garcia, Anastasia Keller-Collins, Meredith Andrews, Yukie Kurumiya, Kaleiya Imlay, Brandon Umphrey, Elizabeth Foster","doi":"10.1177/01454455211027301","DOIUrl":null,"url":null,"abstract":"<p><p>The purpose of this review was to quantitatively synthesize studies using acceptance and commitment therapy (ACT) with individuals with neurodevelopmental disorders (NNDs), their parents, and staff members that support them. Thirty studies published in peer-reviewed journals between 2006 and 2020 met inclusion criteria. They were reviewed and coded on variables associated with participants' characteristics, settings, dropouts, design type, ACT procedures and measures, social validity, treatment integrity, and main findings. The What Works Clearinghouse (WWC), the revised Cochrane risk-of-bias tool for randomized trials (RoB2) and the Risk of Bias in Nonrandomized Studies of Interventions (ROBINS-I) were applied to evaluate the quality of the studies. Results indicated that 20 studies used group designs and 10 studies used single-case designs. Participants with NNDs consisted predominantly of those with autism spectrum disorder, attention deficit hyperactivity disorder, and learning disabilities. Group studies reported process and outcome measures exclusively; whereas, single-case studies also incorporated behavioral/direct measures. Overall, results showed mixed improvements across studies using indirect and direct measures. Lastly, quality assessment for group studies presented moderate or serious risk of bias and two single-case studies did not meet WWC evidence of effectiveness. Directions for future research and practice are discussed.</p>","PeriodicalId":48037,"journal":{"name":"Behavior Modification","volume":null,"pages":null},"PeriodicalIF":2.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/01454455211027301","citationCount":"6","resultStr":"{\"title\":\"Systematic Review of Acceptance and Commitment Therapy in Individuals with Neurodevelopmental Disorders, Caregivers, and Staff.\",\"authors\":\"Yors Garcia, Anastasia Keller-Collins, Meredith Andrews, Yukie Kurumiya, Kaleiya Imlay, Brandon Umphrey, Elizabeth Foster\",\"doi\":\"10.1177/01454455211027301\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The purpose of this review was to quantitatively synthesize studies using acceptance and commitment therapy (ACT) with individuals with neurodevelopmental disorders (NNDs), their parents, and staff members that support them. Thirty studies published in peer-reviewed journals between 2006 and 2020 met inclusion criteria. They were reviewed and coded on variables associated with participants' characteristics, settings, dropouts, design type, ACT procedures and measures, social validity, treatment integrity, and main findings. The What Works Clearinghouse (WWC), the revised Cochrane risk-of-bias tool for randomized trials (RoB2) and the Risk of Bias in Nonrandomized Studies of Interventions (ROBINS-I) were applied to evaluate the quality of the studies. Results indicated that 20 studies used group designs and 10 studies used single-case designs. Participants with NNDs consisted predominantly of those with autism spectrum disorder, attention deficit hyperactivity disorder, and learning disabilities. Group studies reported process and outcome measures exclusively; whereas, single-case studies also incorporated behavioral/direct measures. Overall, results showed mixed improvements across studies using indirect and direct measures. Lastly, quality assessment for group studies presented moderate or serious risk of bias and two single-case studies did not meet WWC evidence of effectiveness. Directions for future research and practice are discussed.</p>\",\"PeriodicalId\":48037,\"journal\":{\"name\":\"Behavior Modification\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2022-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1177/01454455211027301\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Behavior Modification\",\"FirstCategoryId\":\"102\",\"ListUrlMain\":\"https://doi.org/10.1177/01454455211027301\",\"RegionNum\":3,\"RegionCategory\":\"心理学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/6/21 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"PSYCHOLOGY, CLINICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Behavior Modification","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1177/01454455211027301","RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/6/21 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}
引用次数: 6
摘要
本综述的目的是对神经发育障碍(NNDs)患者、他们的父母和支持他们的工作人员使用接受和承诺疗法(ACT)的研究进行定量综合。2006年至2020年间发表在同行评议期刊上的30项研究符合纳入标准。根据与参与者特征、设置、退出、设计类型、ACT程序和措施、社会效度、治疗完整性和主要发现相关的变量对其进行审查和编码。应用What Works Clearinghouse (WWC)、修订后的Cochrane随机试验偏倚风险工具(RoB2)和非随机干预研究的偏倚风险(ROBINS-I)来评估研究的质量。结果表明,20项研究采用分组设计,10项研究采用单病例设计。NNDs的参与者主要包括自闭症谱系障碍、注意缺陷多动障碍和学习障碍。小组研究专门报告了过程和结果测量;然而,单例研究也纳入了行为/直接措施。总体而言,使用间接和直接测量的研究结果显示出混合的改善。最后,对分组研究的质量评估显示有中度或严重的偏倚风险,两项单例研究没有达到WWC有效性的证据。讨论了今后研究和实践的方向。
Systematic Review of Acceptance and Commitment Therapy in Individuals with Neurodevelopmental Disorders, Caregivers, and Staff.
The purpose of this review was to quantitatively synthesize studies using acceptance and commitment therapy (ACT) with individuals with neurodevelopmental disorders (NNDs), their parents, and staff members that support them. Thirty studies published in peer-reviewed journals between 2006 and 2020 met inclusion criteria. They were reviewed and coded on variables associated with participants' characteristics, settings, dropouts, design type, ACT procedures and measures, social validity, treatment integrity, and main findings. The What Works Clearinghouse (WWC), the revised Cochrane risk-of-bias tool for randomized trials (RoB2) and the Risk of Bias in Nonrandomized Studies of Interventions (ROBINS-I) were applied to evaluate the quality of the studies. Results indicated that 20 studies used group designs and 10 studies used single-case designs. Participants with NNDs consisted predominantly of those with autism spectrum disorder, attention deficit hyperactivity disorder, and learning disabilities. Group studies reported process and outcome measures exclusively; whereas, single-case studies also incorporated behavioral/direct measures. Overall, results showed mixed improvements across studies using indirect and direct measures. Lastly, quality assessment for group studies presented moderate or serious risk of bias and two single-case studies did not meet WWC evidence of effectiveness. Directions for future research and practice are discussed.
期刊介绍:
For two decades, researchers and practitioners have turned to Behavior Modification for current scholarship on applied behavior modification. Starting in 1995, in addition to keeping you informed on assessment and modification techniques relevant to psychiatric, clinical, education, and rehabilitation settings, Behavior Modification revised and expanded its focus to include treatment manuals and program descriptions. With these features you can follow the process of clinical research and see how it can be applied to your own work. And, with Behavior Modification, successful clinical and administrative experts have an outlet for sharing their solutions in the field.